The levels of angiogenic molecules such as VEGF, VEGFR1, VEGFR2, angiopoietins, and tyrosine-protein kinase receptor-2 (TIE-2) are decreased in human and experimental BPD [44,45,46,47,48]. This evidence concerns the gene VEGFA and bronchopulmonary dysplasia.